CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Elanco Animal Health Inc

ELAN
$12.10B
Large Cap
NASDAQPharmaceutical PreparationsPharmaceutical (animal)🇺🇸North AmericaINDIANAPOLIS9.4K employees

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.

Website

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

ELAN News
Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

How ELAN's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is Elanco Animal Health Inc's next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for Elanco Animal Health Inc (ELAN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track ELAN biotech catalysts?

Add ELAN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Elanco Animal Health Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply